John W. Babich serves as Executive at Molecular Insight Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John W. Babich has executed 9 insider transactions totaling $89.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 20, 2008 involved receiving (via award) 30,000 shares valued at $0.
John W. Babich currently holds 185,906 shares of Molecular Insight Pharmaceuticals, Inc. (MIPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John W. Babich has been a net buyer of MIPI stock. They have purchased $89.5K and sold $0 worth of shares.
John W. Babich's most recent insider trade was on May 20, 2008, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.35 |
| Discretionary |
| Nov 30, 2007 | MIPI | $5.0K | Purchase | 600 | $8.34 | Discretionary |
| Nov 20, 2007 | MIPI | $43.9K | Purchase | 6,500 | $6.75 | Discretionary |
| Nov 20, 2007 | MIPI | $24.7K | Purchase | 3,500 | $7.06 | Discretionary |
| Feb 28, 2007 | MIPI | $0 | Other | 49,333 | $N/A | Discretionary |
| Feb 28, 2007 | MIPI | $0 | Other | 49,333 | $N/A | Discretionary |
| Feb 28, 2007 | MIPI | $48.0K | Option Exercise | 80,000 | $0.60 | Discretionary |
| Feb 1, 2007 | MIPI | $0 | Conversion | 27,702 | $N/A | Discretionary |